Australian Enterococcal Sepsis Outcome Progamme, 2011.

QR Code

Australian Enterococcal Sepsis Outcome Progamme, 2011.

From 1 January to 31 December 2011, 29 institutions around Australia participated in the Australian Enterococcal Sepsis Outcome Programme (AESOP). The aim of AESOP 2011 was to determine the proportion of enterococcal bacteraemia isolates in Australia that are antimicrobial resistant, with particular...

Full description

Bibliographic Details
Main Authors:	Coombs, Geoffrey, Pearson, J., Le, T., Daly, D., Robinson, J., Gottlieb, T., Howden, B., Johnson, P., Bennett, C., Stinear, T., Turnidge, J., Australian Group on Antimicrobial Resistance
Format:	Journal Article
Published:	2014
Online Access:	http://hdl.handle.net/20.500.11937/14568

Similar Items

Australian Enterococcal Sepsis Outcome Progamme, 2011
by: Coombs, Geoffrey, et al.
Published: (2014)

Australian Enterococcal Sepsis Outcome Programme annual report, 2013
by: Coombs, Geoffrey, et al.
Published: (2014)

Molecular Epidemiology of Enterococcal Bacteremia in Australia
by: Coombs, Geoffrey, et al.
Published: (2014)

Hospital-onset Gram-negative Surveillance Program annual report, 2011.
by: Turnidge, J., et al.
Published: (2014)

Community-onset Gram-negative Surveillance Program annual report, 2012.
by: Turnidge, J., et al.
Published: (2014)

Community-onset Staphylococcus aureus Surveillance Programme annual report, 2012.
by: Coombs, Geoffrey, et al.
Published: (2014)

Enterobacteriaceae Sepsis Outcome Programme annual report, 2013
by: Turnidge, J., et al.
Published: (2014)

Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013
by: Coombs, Geoffrey, et al.
Published: (2014)

Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010
by: Turnidge, J., et al.
Published: (2013)

Antimicrobial susceptibility of Staphylococcus aureus and molecular epidemiology of meticillin-resistant S. aureus isolated from Australian hospital inpatients: Report from the Australian Group on Antimicrobial Resistance 2011 Staphylococcus aureus Surveillance Programme
by: Coombs, Geoffrey, et al.
Published: (2013)

Australian Group on Antimicrobial Resistance Enterococcus Surveillance Programme annual report, 2010
by: Coombs, Geoffrey, et al.
Published: (2013)

Australian Group on Antimicrobial Resistance Hospital-onset Staphylococcus aureus Surveillance Programme annual report, 2011
by: Coombs, Geoffrey, et al.
Published: (2013)

The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct
by: Chua, K., et al.
Published: (2011)

Insulin Sensitivity and Sepsis Score: A Correlation between Model-based Metric and Sepsis Scoring System in Critically Ill Patients
by: Fatanah, M. Suhaimi, et al.
Published: (2017)

Identification and antimicrobial susceptibility of enterococcal species isolated from cats exposed to different antibiotics
by: Mohd Amin, Nor Azimah
Published: (2016)

A change in the molecular epidemiology of vancomycin resistant enterococci in Western Australia
by: Coombs, Geoffrey, et al.
Published: (2014)

Insulin Sensitivity as a Model-Based Marker for Sepsis Diagnosis
by: Fatanah, M. Suhaimi, et al.
Published: (2015)

Modeling of insulin sensitivity for Sepsis-AKI and Sepsis Non-AKI
by: Farhah, M., et al.
Published: (2022)

Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus
by: Coombs, Geoffrey, et al.
Published: (2014)

Genomic insights to control the emergence of vancomycin-resistant enterococci
by: Howden, B., et al.
Published: (2013)

Evaluation of the BD GeneOhm MRSA ACP Assay and the Cepheid GeneXpert MRSA Assay to detect genetically diverse CA-MRSA.
by: Coombs, Geoffrey, et al.
Published: (2013)

Blood glucose and sepsis score on sepsis patients requiring insulin therapy
by: Mohamad Suhaimi, Fatanah, et al.
Published: (2018)

Adaptive Change Inferred from Genomic Population Analysis of the ST93 Epidemic Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus
by: Stinear, T., et al.
Published: (2014)

Antibiotic choice may not explain poorer outcomes in patients with staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations
by: Holmes, N., et al.
Published: (2011)

Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia
by: Bennett, C., et al.
Published: (2013)

Evolutionary origins of the emergent ST796 clone of vancomycin resistant Enterococcus faecium
by: Buultjens, A., et al.
Published: (2017)

Hyperexpression of a-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus
by: Chua, K., et al.
Published: (2014)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Surviving sepsis campaign - The Sequel
by: Leslie, Gavin
Published: (2008)

Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: A 10-year retrospective review
by: Robinson, James, et al.
Published: (2009)

Isolation of coagulase negative Enterococcous sp. strains from non-broiler chicken producing bacteriocin active against Staphylococcus aureus
by: Alhaji Yusuf, Moshood, et al.
Published: (2013)

One-Year Survival And Performance Status In Adult Patients With Sepsis, Severe Sepsis, And Septic Shock
by: Alkhalaf, Mustafa Salman M.
Published: (2013)

Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus
by: Baines, S., et al.
Published: (2015)

Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates
by: Holmes, N., et al.
Published: (2014)

Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: Report from the Australian Group on Antimicrobial Resistance
by: Nimmo, G., et al.
Published: (2011)

Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
by: Phillips, M., et al.
Published: (2013)

Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: A case control study
by: Boan, P., et al.
Published: (2015)

Biomarkers approach in the diagnosis and prognosis of sepsis
by: Mahnaz, Irani-Shemirani
Published: (2022)

Parameters Predicting Clinical Sepsis In Neonates
by: Aldelimi, Ahlam Abulqasem
Published: (2015)

Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control study
by: Wehrhahn, M., et al.
Published: (2010)